ZELMINEMAB
UNII KTN6S97T6D

Substance Identification & Data

This profile provides standardized clinical and technical data for Zelminemab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) KTN6S97T6D.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2225850-33-7 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
KTN6S97T6D
CAS Registry Number
2225850-33-7
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
ZELMINEMAB
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C171843
National Cancer Institute reference terminology for clinical and research data.
INN ID
11091
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Zelminemab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

ZELMINEMAB

Common Names & Synonyms

IMMUNOGLOBULIN G1 (300-GLYCINE), ANTI-(HUMAN PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE RECEPTOR PAC1) (HUMAN MONOCLONAL 29G4V22 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL 29G4V22 .KAPPA.-CHAIN, DIMER
ZELMINEMAB [INN]

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus